DSN looks back on the past year's most influential events in the pharmacy industry, from Obamacare and record patent expirations to Humira surpassing Lipitor as the world's top-selling drug and the merger of Walgreens and Alliance Boots.
The year 2012 is coming to an end, and it's been a big year for generic drugs. It's the year that the most lucrative drug of all time became commoditized. It's the year that Watson bought Actavis for $5.6 billion. And it's the year the FDA released draft guidance for biosimilars regulations. All of these events speak to some of the most important trends in the world of generics — trends that are often interrelated.
Walmart is rapidly expanding its impact on pharmacy by opening its smaller 45,000-sq.-ft. Neighborhood Market stores at a faster pace, while also experimenting with the even smaller 15,000-sq.-ft. Walmart Express format.
With healthcare reform on track to bring 32 million more Americans into the healthcare system in 2014, and with payers and patients looking for solutions to curb costs as the nation battles a shortage of primary care physicians and access to quality care, CVS Caremark’s role in reinventing pharmacy through its distinctive business model couldn’t be more imperative than it is today.
As the debate over healthcare reform in the United States rages — sometimes palpably so — a new report from healthcare market research firm IMS Health indicated that a major shift in drug-spending trends is under way between developed countries like the United States and developing countries.